ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 3 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -99.6% | 2,000 | -98.8% | 0.00% | – |
| Q2 2023 | $231 | +22.2% | 166,800 | +40.3% | 0.00% | – |
| Q1 2023 | $189 | -90.6% | 118,900 | -63.4% | 0.00% | -100.0% |
| Q4 2022 | $2,021 | -99.4% | 324,500 | +530.1% | 0.00% | – |
| Q3 2022 | $345,000 | -49.2% | 51,500 | -51.8% | 0.00% | -100.0% |
| Q2 2022 | $679,000 | +2325.0% | 106,900 | +1652.5% | 0.00% | – |
| Q1 2022 | $28,000 | -73.6% | 6,100 | -71.4% | 0.00% | – |
| Q4 2021 | $106,000 | -33.8% | 21,300 | +184.0% | 0.00% | – |
| Q3 2021 | $160,000 | +1.3% | 7,500 | 0.0% | 0.00% | – |
| Q2 2021 | $158,000 | -91.6% | 7,500 | +1019.4% | 0.00% | -100.0% |
| Q1 2021 | $1,879,000 | +184.7% | 670 | +163.8% | 0.00% | +200.0% |
| Q4 2020 | $660,000 | +14.0% | 254 | +62.8% | 0.00% | 0.0% |
| Q3 2020 | $579,000 | -56.2% | 156 | -39.5% | 0.00% | -50.0% |
| Q2 2020 | $1,323,000 | -9.9% | 258 | -44.6% | 0.00% | -33.3% |
| Q1 2020 | $1,469,000 | -22.0% | 466 | +47.5% | 0.00% | -25.0% |
| Q4 2019 | $1,884,000 | +77.9% | 316 | +9.3% | 0.00% | +33.3% |
| Q3 2019 | $1,059,000 | -24.4% | 289 | -4.0% | 0.00% | -25.0% |
| Q2 2019 | $1,400,000 | -12.1% | 301 | -24.2% | 0.00% | 0.0% |
| Q1 2019 | $1,593,000 | -29.6% | 397 | -19.3% | 0.00% | -42.9% |
| Q4 2018 | $2,263,000 | -38.6% | 492 | -40.8% | 0.01% | -41.7% |
| Q3 2018 | $3,687,000 | +69.5% | 831 | +49.7% | 0.01% | +33.3% |
| Q2 2018 | $2,175,000 | +1877.3% | 555 | +114.3% | 0.01% | +80.0% |
| Q1 2018 | $110,000 | +266.7% | 259 | +502.3% | 0.01% | +400.0% |
| Q4 2017 | $30,000 | +233.3% | 43 | -23.2% | 0.00% | – |
| Q3 2017 | $9,000 | -78.6% | 56 | -92.8% | 0.00% | -100.0% |
| Q2 2017 | $42,000 | -81.7% | 779 | -51.5% | 0.00% | -80.0% |
| Q1 2017 | $229,000 | – | 1,607 | +19987.5% | 0.01% | – |
| Q4 2016 | $0 | -100.0% | 8 | -52.9% | 0.00% | -100.0% |
| Q3 2016 | $19,000 | 0.0% | 17 | -59.5% | 0.00% | 0.0% |
| Q2 2016 | $19,000 | +280.0% | 42 | +90.9% | 0.00% | – |
| Q1 2016 | $5,000 | -99.3% | 22 | -81.4% | 0.00% | -100.0% |
| Q4 2015 | $736,000 | -25.3% | 118 | -45.6% | 0.06% | -19.4% |
| Q3 2015 | $985,000 | +320.9% | 217 | -1.8% | 0.07% | +260.0% |
| Q2 2015 | $234,000 | +36.8% | 221 | +35.6% | 0.02% | 0.0% |
| Q1 2015 | $171,000 | +8450.0% | 163 | +918.8% | 0.02% | – |
| Q4 2014 | $2,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 12,106 | $87,562,000 | 5.23% |
| Iguana Healthcare Management, LLC | 50,000 | $3,617,000 | 2.38% |
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $1,367,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 37,900 | $2,741,000 | 0.03% |
| SIMPLEX TRADING, LLC | 259 | $110,000 | 0.01% |